(1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one | 1331828-01-3

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - Oxamorphinans
• 英文名称: (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one
• 英文别名: (1R,2R,3S,6S,9S,10R)-5-benzyl-20-(cyclopropylmethyl)-6,16-dihydroxy-15-methoxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-4-one
• CAS: 1331828-01-3
• 化学式: C₃₀H₃₄N₂O₅
• 分子量: 502.61
• InChiKey: GGKIVHDNBHPNFR-HJGLZJKISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  37
• 可旋转键数：
  5
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  82.5
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one 在 potassium carbonate 、 氯甲酸-2,2,2-三氯乙酯 、 溶剂黄146 、 锌 作用下， 以 1,1,2,2-四氯乙烷 为溶剂， 反应 22.0h， 以80%的产率得到(1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one
  参考文献：
  名称：

  Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure

  摘要：

  We synthesized compounds 4a,c-f,h,i containing the oxazatricyclodecane structure from a novel rearrangement reaction product 2a. All the prepared compounds 4a,c-f,h,i exhibited full agonistic activities for the delta opioid receptor (DOR). Among them, the N-methyl derivative 4c was highly selective, and the most effective DOR agonist in functional assays. Subcutaneous administration of 4c produced dose-dependent and NTI (selective DOR antagonist)-reversible antinociception lacking any convulsive behaviors in the mice acetic acid writhing tests. The N-methyl derivative 4c is expected to be a promising lead compound for selective DOR agonists with a novel chemotype.

  DOI：

  10.1021/ml400491k
• 作为产物：
  描述：

  ethyl (2S,3R,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate 在 正丁基锂 、 potassium tert-butylate 作用下， 以 四氢呋喃 、 正己烷 、 叔丁醇 为溶剂， 反应 2.25h， 生成 (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one
  参考文献：
  名称：

  4,5α-环氧吗啡喃衍生物与氨基甲酰基环氧环的重排提供了新的氧杂三环癸烷结构

  摘要：

  我们描述了氨基甲酰环氧4,5α-环氧吗啡喃衍生物的重排，该衍生物通过氧杂双环[2.2.2]辛烷中间体提供具有氧杂三环癸烷结构的新型4,5α-环氧吗啡喃衍生物。我们基于在不同去质子化条件下观察到的结果提出了重排反应的机理。差向异构在重排过程中发生在可逆但不可逆的去质子化条件下。重排产物具有对阿片样物质受体具有中等亲和力的新颖基本结构（K i（μ）= 47.7 nM，K i（δ）= 174.6 nM和K i（κ）= 248.1 nM）。因此，重排产物作为阿片样物质配体可能具有高效力。

  DOI：

  10.1016/j.tet.2011.04.097

文献信息

• MORPHINAN DERIVATIVE
  申请人：The Kitasato Institute

  公开号：EP2774926B1

  公开（公告）日：2017-03-15
• Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities
  作者：Kohei Hayashida、Shigeto Hirayama、Takashi Iwai、Yoshikazu Watanabe、Toshihiro Takahashi、Junichi Sakai、Eriko Nakata、Tomio Yamakawa、Hideaki Fujii、Hiroshi Nagase

  DOI：10.1016/j.bmcl.2017.04.059

  日期：2017.6

  We recently reported oxazatricyclodecane derivatives 1 as delta opioid receptor (DOR) agonists having a novel chemotype, but their DOR agonistic activities were relatively low. Based on the working hypothesis that the dioxamethylene moiety in 1 may be an accessory site and that it may interfere with the sufficient conformational change of the receptor required for exerting the full agonistic responses, we designed and synthesized new oxazatricyclodecane derivatives 2-4 lacking the dioxamethylene moiety. As we expected, the designed compounds 2-4 showed pronouncedly improved agonistic activities for the DOR. Compound 2a with the 17-cyclopropylmethyl substituent was a potent agonist with the highest selectivity for the DOR and was expected to be a lead compound for novel and selective DOR agonists. (C) 2017 Elsevier Ltd. All rights reserved.
• US20140343015A1
  申请人：——

  公开号：US20140343015A1

  公开（公告）日：2014-11-20
• US8952030B2
  申请人：——

  公开号：US8952030B2

  公开（公告）日：2015-02-10
• Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure
  作者：Hideaki Fujii、Kohei Hayashida、Akiyoshi Saitoh、Akinobu Yokoyama、Shigeto Hirayama、Takashi Iwai、Eriko Nakata、Toru Nemoto、Yuka Sudo、Yasuhito Uezono、Mitsuhiko Yamada、Hiroshi Nagase

  DOI：10.1021/ml400491k

  日期：2014.4.10

  We synthesized compounds 4a,c-f,h,i containing the oxazatricyclodecane structure from a novel rearrangement reaction product 2a. All the prepared compounds 4a,c-f,h,i exhibited full agonistic activities for the delta opioid receptor (DOR). Among them, the N-methyl derivative 4c was highly selective, and the most effective DOR agonist in functional assays. Subcutaneous administration of 4c produced dose-dependent and NTI (selective DOR antagonist)-reversible antinociception lacking any convulsive behaviors in the mice acetic acid writhing tests. The N-methyl derivative 4c is expected to be a promising lead compound for selective DOR agonists with a novel chemotype.